HWAM
AVXL icon

Hennion & Walsh Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Hennion & Walsh Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-59,550
Closed -$390K – 819
2023
Q3 		$390K Sell
59,550
-11,757
-16% -$93.6K 0.02% 592
2023
Q2 		$580K Buy
71,307
+749
+1% +$6.42K 0.03% 473
2023
Q1 		$605K Sell
70,558
-1,658
-2% -$16.5K 0.04% 467
2022
Q4 		$669K Buy
72,216
+5,757
+9% +$61.5K 0.04% 429
2022
Q3 		$686K Sell
66,459
-2,229
-3% -$23.5K 0.05% 418
2022
Q2 		$688K Buy
68,688
+6,629
+11% +$62.8K 0.04% 411
2022
Q1 		$764K Buy
62,059
+24,503
+65% +$301K 0.04% 408
2021
Q4 		$651K Buy
+37,556
New +$714K 0.03% 473

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return